Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nicolas Ceze"'
Autor:
Etienne Dorval, Anne-Claire Duveau, David Ternant, Thierry Lecomte, Danielle Degenne, Hervé Watier, Nicolas Ceze, Gilles Paintaud
Publikováno v:
Ther. Drug Monit.
Ther. Drug Monit., 2010, 32 (5), pp.647-652
Ther. Drug Monit., 2010, 32 (5), pp.647-652
International audience; Introduction: Bevacizumab is an antivascular endothelial growth factor humanized monoclonal antibody used to inhibit angiogenesis in cancer. It displays an important interindividual pharmacokinetic variability, which could exp
Publikováno v:
médecine/sciences. 25:1099-1104
The development of therapeutic monoclonal antibodies (mAb) provided many great advances in the treatment of some diseases, in particular cancers. In the treatment of cancers, tumour angiogenesis inhibition by mAb occupies a major place. Tumour angiog
Autor:
Danielle Degenne, Gilles Paintaud, Nicolas Ceze, Hervé Watier, Etienne Dorval, Nicolas Azzopardi, Friedrich Piller, Thierry Lecomte, David Ternant
Publikováno v:
Ther. Drug Monit.
Ther. Drug Monit., 2009, 31 (5), pp.597-601
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2009, 31 (5), pp.597-601
Ther. Drug Monit., 2009, 31 (5), pp.597-601
Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2009, 31 (5), pp.597-601
International audience; Cetuximab is anti-epidermal growth factor receptor monoclonal antibody used in the treatment of colorectal and head and neck cancers. Part of the interindividual differences in response may be explained by interindividual vari
Autor:
Etienne Dorval, Driffa Moussata, Jean-Pierre Barbieux, Nicolas Ceze, Emmanuel Mitry, Thierry Lecomte, Thomas Aparicio, Christophe Locher, Antoine Charachon, Bruno Landi
Publikováno v:
Clinics and research in hepatology and gastroenterology. 40(2)
Summary Purpose Self-expandable metallic stent (SEMS) placement is an accepted palliative therapy for management of acute malignant bowel obstruction in advanced colorectal cancer. Nevertheless, data are lacking on the effects of systemic chemotherap
Autor:
G. Goujon, Hervé Watier, G. Thibault, Nicolas Ceze, J. Viguier, Thierry Lecomte, Etienne Dorval
Publikováno v:
Cancer chemotherapy and pharmacology. 68(5)
Lymphopenia is a predictor of the efficacy and hematological toxicity of chemotherapy in various advanced cancers. There is little data about this relationship in colorectal cancer. In this retrospective study, the influence of pretreatment lymphopen
Autor:
A. Aubourg, J. Viguier, JP Barbieux, Etienne Dorval, Nicolas Ceze, A Bocoum, B Godart, Thierry Lecomte
Publikováno v:
Endoscopy. 42
Autor:
Nicolas, Ceze, Alicia, Probst, Thierry, Lecomte, Marc, Ohresser, Gilles, Paintaud, Hervé, Watier
Publikováno v:
Bulletin du cancer. 94
Targeted therapies, especially monoclonal antibodies, have reached an increasing importance in oncology. High-throughput techniques have allowed the identification of numerous transcripts, proteins, or non-protein antigens, which have generated the c
Publikováno v:
Gastroentérologie Clinique et Biologique. 30:330-331
Parmi les nombreux types histologiques de tumeurs appendiculaires, sont classiquement individualisees plusieurs varietes a double differenciation, a la fois exocrine et endocrine.
Publikováno v:
Gastroentérologie Clinique et Biologique. 33:A150
Introduction Le cancer colorectal (CCR) releve souvent d’un traitement par chimiotherapie (CT). Peu de facteurs predictifs de toxicite et d’efficacite de la CT ont ete rapportes. Il a ete montre pour certains cancers que la lymphopenie (LP) etait